Origen de la red de primer grado Ingmar Hoerr.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.
16
| Subsidiary | Biotechnology | 16 |
13
| Public Company | Pharmaceuticals: Major | 13 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Ingmar Hoerr a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| 2INVEST AG | Financial Conglomerates | Director/Board Member Compliance Officer | |
| UBS | Investment Managers | Corporate Officer/Principal | |
| PAION AG | Pharmaceuticals: Major | Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Public Communications Contact | |
| TIGENIX NV | Medical Specialties | Chairman Chairman | |
| GROUPE BRUXELLES LAMBERT SA | Financial Conglomerates | Director/Board Member Director/Board Member | |
| BIOTEST AG | Pharmaceuticals: Other | Corporate Officer/Principal | |
20 Minuten-Holding AG
 20 Minuten-Holding AG Publishing: NewspapersConsumer Services Part of Schibsted ASA, 20 Minuten-Holding AG is a holding group with interests in publishing. The company is based in Zurich, Switzerland. The Swiss company was founded by Hans Christoph Tanner. Sverre Christian Munck has been the CEO of the company since 2002. | Publishing: Newspapers | Founder | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chairman Corporate Officer/Principal | |
Ernst Mueller Moehl
 Ernst Mueller Moehl Investment Banks/BrokersFinance Ernst Mueller Moehl provides investment services. The private company is based in Zurich, Switzerland. and has subsidiaries in Switzerland. | Investment Banks/Brokers | Corporate Officer/Principal | |
| BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member Director/Board Member | |
| The University of Edinburgh | College/University | Graduate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DKSH HOLDING AG | Medical Distributors | Director/Board Member | |
| London School of Economics & Political Science | College/University | Undergraduate Degree | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
| University of Mannheim | College/University | Undergraduate Degree | |
| Universität Saarbrücken | College/University | Graduate Degree | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
| Otto-von-Guericke-Universität Magdeburg | College/University | Doctorate Degree | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Chief Executive Officer | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
UBS Australia Pty Ltd.
 UBS Australia Pty Ltd. Investment ManagersFinance Part of UBS Group AG, UBS Australia Pty Ltd. is an Australian company that provides wealth management, asset management and investment banking services. The company is based in Sydney, Australia. The CEO of the company is Matthew Grounds. | Investment Managers | Corporate Officer/Principal | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
Qvanteq AG
 Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Biotechnology | Director/Board Member | |
| PIXIUM VISION | Medical Specialties | Director of Finance/CFO | |
BePharBel Manufacturing SA
 BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
OncoDNA SA
 OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chairman Director/Board Member | |
| ESB Business School | College/University | Masters Business Admin | |
dievini patch Beteiligungs GmbH
 dievini patch Beteiligungs GmbH Financial ConglomeratesFinance dievini patch Beteiligungs GmbH provides investment services. The company is headquartered in Andernach, Germany. | Financial Conglomerates | Chief Executive Officer | |
| COSMO PHARMACEUTICALS N.V. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Vaxxilon AG
 Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The company is based in Reinach, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
FARa Holz AG
 FARa Holz AG Forest ProductsNon-Energy Minerals FARa Holz AG is a timber trading company based in Zug, Switzerland. FARa Holz is located at Sagistrasse 10, 6300 Zug, Switzerland. The Swiss company specializes in providing wood materials for construction, including wooden structures, cover parking chains, and laminated wood. The private company also offers wood declaration services, advice, and technology. FARa Holz has a team of specialists with many years of experience in the timber trade, and they cater to wooden builders, carpenters, floor layers, roofers, and other woodworking companies. The company also provides advice to architects and construction planners. The company's mission is to have the most satisfied customers in their performance area and the most motivated employees. | Forest Products | Director/Board Member | |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
Curevac Aktiebolag
 Curevac Aktiebolag Containers/PackagingProcess Industries Part of Curevac International AB, Curevac Aktiebolag is a Swedish company that manufactures vacuum bags for smaller food producers. The company is based in Gothenburg, Sweden. Franz-Werner Haas has been the CEO of the company since 2012. | Containers/Packaging | Chief Executive Officer | |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
 TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG is a German company based in Walldorf, Germany. TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG provides real estate services. The private company was founded in 2008, and its CEOs are Dietmar Hopp, Oliver Hopp, and Mathias Hothum. | Real Estate Development | Chief Executive Officer | |
Wyss Zurich
 Wyss Zurich Investment ManagersFinance Wyss Zurich is an accelerator/incubator with headquarters in Zurich, Switzerland. The firm was founded in 2015. | Investment Managers | Director/Board Member | |
CureVac Real Estate GmbH
 CureVac Real Estate GmbH Real Estate DevelopmentFinance CureVac Real Estate GmbH manages commercial and non-residential buildings. The company is headquartered in Tuebingen, Germany. | Real Estate Development | Chief Executive Officer | |
LimmaTech Biologics AG
 LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Chief Executive Officer | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
BESIX Group NV
 BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Chairman Director/Board Member |
Estadísticas
Internacional
| Alemania | 22 |
| Suiza | 12 |
| Bélgica | 9 |
| Francia | 3 |
| Italia | 3 |
Sectorial
| Health Technology | 20 |
| Finance | 14 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Distribution Services | 2 |
Operativa
| Director/Board Member | 112 |
| Chairman | 40 |
| Corporate Officer/Principal | 34 |
| Chief Executive Officer | 24 |
| Independent Dir/Board Member | 18 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Friedrich von Bohlen und Halbach | 36 |
| Baron Jean Stéphenne | 36 |
| Hans Tanner | 24 |
| Craig Tooman | 22 |
| Mathias Hothum | 19 |
| Michael Brosnan | 14 |
| Ralf Clemens | 14 |
| Timothy M. Wright | 13 |
| Jean Stephenne | 12 |
| Debra Stephanie Barker | 11 |
| Franz-Werner Haas | 9 |
| Igor Splawski | 8 |
| Florian von der Muelbe | 6 |
| Pierre Kemula | 5 |
| Bernd Winterhalter | 5 |
- Bolsa de valores
- Insiders
- Ingmar Hoerr
- Conexiones Empresas
